長電科技(600584.SH)擬定增募資不超50億元 用於年產36億顆高密度集成電路及系統級封裝模塊項目等
格隆匯 8 月 20日丨長電科技(600584.SH)披露2020年度非公開發行A股股票預案,公司此次非公開發行擬募集資金總額不超過50億元(含50億元),扣除發行費用後的募集資金淨額將全部投入以下項目:26.6億元用於年產36億顆高密度集成電路及系統級封裝模塊項目;8.4億元用於年產100億塊通信用高密度混合集成電路及模塊封裝項目;15億元用於償還銀行貸款及短期融資券。
此次非公開發行股票的數量為募集資金總額除以此次非公開發行股票的發行價格,且不超過此次發行前公司總股本的11.23%,即不超過1.8億股(含1.8億股)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.